{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Fibrositis", "query": { "condition": "Fibrositis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 386, "total_pages": 39, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Fibrositis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-24T18:11:04.806Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00464737", "title": "The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fibromyalgia Syndrome" ], "interventions": [ { "name": "Rotigotine", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 230, "start_date": "2007-03", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2015-06-22", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 35, "location_summary": "Mobile, Alabama • Mesa, Arizona • Peoria, Arizona + 32 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Santa Ana", "state": "California" }, { "city": "Cromwell", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00464737" }, { "nct_id": "NCT01748786", "title": "Online Mindfulness Training Versus Health Education for Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Mindfulness Emotion Regulation", "type": "BEHAVIORAL" }, { "name": "Health Education", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Arizona State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 94, "start_date": "2011-01", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2016-02-23", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01748786" }, { "nct_id": "NCT01693692", "title": "Phase 2 Study of TD-9855 to Treat Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "TD-9855 Group 1", "type": "DRUG" }, { "name": "TD-9855 Group 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Theravance Biopharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 392, "start_date": "2012-11", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2022-03-04", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 34, "location_summary": "Huntsville, Alabama • Goodyear, Arizona • El Cajon, California + 31 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "El Cajon", "state": "California" }, { "city": "Pismo Beach", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01693692" }, { "nct_id": "NCT01333566", "title": "Qigong Exercise May Benefit Patients With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Intervention Group", "type": "BEHAVIORAL" }, { "name": "Placebo Comparator: Control Group", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 35, "start_date": "2009-07", "completion_date": "2015-02", "has_results": false, "last_update_posted_date": "2016-07-04", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01333566" }, { "nct_id": "NCT01315210", "title": "D-Ribose for Fatigue in Subjects With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "D-Ribose Powder", "type": "DRUG" }, { "name": "Placebo Powder", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "RiboCor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 110, "start_date": "2011-05", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2013-09-18", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 9, "location_summary": "Sacramento, California • DeLand, Florida • Ocala, Florida + 6 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Columbia", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01315210" }, { "nct_id": "NCT00883740", "title": "Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia", "Sleep Disorders" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2009-06", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2021-01-25", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Tucson, Arizona • San Diego, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00883740" }, { "nct_id": "NCT03249103", "title": "Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "NYX-2925", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aptinyx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "18 Years to 70 Years · Female only" }, "enrollment_count": 22, "start_date": "2017-08-14", "completion_date": "2019-04-18", "has_results": true, "last_update_posted_date": "2022-09-16", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 2, "location_summary": "Ann Arbor, Michigan • Cincinnati, Ohio", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03249103" }, { "nct_id": "NCT00001983", "title": "Eligibility Screening for National Institute of Dental and Craniofacial Research Studies", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Fibromyalgia" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Dental and Craniofacial Research (NIDCR)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 300, "start_date": "2000-01", "completion_date": "2003-12", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001983" }, { "nct_id": "NCT05998369", "title": "Empowered Relief for Youth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain", "Musculoskeletal Pain", "Fibromyalgia", "Neuropathic Pain", "Complex Regional Pain Syndromes", "Abdominal Pain" ], "interventions": [ { "name": "Empowered Relief for Youth", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "10 Years to 18 Years" }, "enrollment_count": 110, "start_date": "2023-08-09", "completion_date": "2025-04-01", "has_results": false, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05998369" }, { "nct_id": "NCT07398417", "title": "Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "AXS-14 (Esreboxetine)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 620, "start_date": "2026-01-14", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-07-24T18:11:04.806Z", "location_count": 51, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 44 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07398417" } ] }